Literature DB >> 32979189

Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression.

W Li1, L Jin1, Y Cui1, A Nie1, N Xie2, G Liang3.   

Abstract

AIM: Diabetic retinopathy (DR) is a chronic disease causing health and economic burdens on individuals and society. Thus, this study is conducted to figure out the mechanisms of bone marrow mesenchymal stem cells (BMSCs)-induced exosomal microRNA-486-3p (miR-486-3p) in DR.
METHODS: The putative miR-486-3p binding sites to 3'untranslated region of Toll-like receptor 4 (TLR4) was verified by luciferase reporter assay. High glucose (HG)-treated Muller cells were transfected with miR-486-3p or TLR4-related oligonucleotides and plasmids to explore theirs functions in DR. Additionally, HG-treated Muller cells were co-cultured with BMSC-derived exosomes, exosomes collected from BMSCs that had been transfected with miR-486-3p or TLR4-related oligonucleotides and plasmids to explore their functions in DR. MiR-486-3p, TLR4 and nuclear factor-kappaB (NF-κB) expression, angiogenesis-related factors, oxidative stress factors, viability and apoptosis in HG-treated Muller cells were detected by RT-qPCR, western blot analysis, ELISA, MTT assay and flow cytometry, respectively.
RESULTS: MiR-486-3p was poorly expressed while TLR4 and NF-κB were highly expressed in HG-treated Muller cells. TLR4 was a target of miR-486-3p. Upregulating miR-486-3p or down-regulating TLR4 inhibited oxidative stress, inflammation and apoptosis, and promoted proliferation of HG-treated Muller cells. Meanwhile, BMSC-derived exosomes inhibited oxidative stress, inflammation and apoptosis, and promoted proliferation of HG-treated Muller cells. Restoring miR-486-3p further enhanced, while up-regulating TLR4 reversed, the improvement of exosomes treatment.
CONCLUSION: Our study highlights that up-regulation of miR-486-3p induced by BMSC-derived exosomes played a protective role in DR mice via TLR4/NF-κB axis repression.

Entities:  

Keywords:  Bone marrow mesenchymal stem cells; Diabetic retinopathy; Exosomes; MicroRNA-486-3p; NF-κb signaling pathway; Toll-like receptor 4

Year:  2020        PMID: 32979189     DOI: 10.1007/s40618-020-01405-3

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  53 in total

Review 1.  Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.

Authors:  Agnese Fiori; Vincenzo Terlizzi; Heiner Kremer; Julian Gebauer; Hans-Peter Hammes; Martin C Harmsen; Karen Bieback
Journal:  Immunobiology       Date:  2018-02-15       Impact factor: 3.144

2.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

3.  Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Diabetic Retinopathy.

Authors:  Xianliang Gu; Xi Yu; Chen Zhao; Ping Duan; Tongtao Zhao; Yong Liu; Shiying Li; Zhi Yang; Yunyan Li; Cheng Qian; Zhengqin Yin; Yi Wang
Journal:  Cell Physiol Biochem       Date:  2018-08-22

4.  Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion.

Authors:  Biji Mathew; Sriram Ravindran; Xiaorong Liu; Leianne Torres; Mohansrinivas Chennakesavalu; Chun-Chieh Huang; Liang Feng; Ruth Zelka; Jasmine Lopez; Monica Sharma; Steven Roth
Journal:  Biomaterials       Date:  2019-01-09       Impact factor: 12.479

Review 5.  Artificial intelligence for diabetic retinopathy screening, prediction and management.

Authors:  Dinesh V Gunasekeran; Daniel S W Ting; Gavin S W Tan; Tien Y Wong
Journal:  Curr Opin Ophthalmol       Date:  2020-09       Impact factor: 3.761

6.  Transfection with CXCR4 potentiates homing of mesenchymal stem cells in vitro and therapy of diabetic retinopathy in vivo.

Authors:  Jian Wang; Wei Zhang; Guang-Hui He; Bin Wu; Song Chen
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

7.  A survey on medical image analysis in diabetic retinopathy.

Authors:  Skylar Stolte; Ruogu Fang
Journal:  Med Image Anal       Date:  2020-05-30       Impact factor: 8.545

Review 8.  A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction.

Authors:  Chi Miao; Mingming Lei; Weina Hu; Shuo Han; Qi Wang
Journal:  Stem Cell Res Ther       Date:  2017-11-02       Impact factor: 6.832

Review 9.  Novel stem cell and gene therapy in diabetic retinopathy, age related macular degeneration, and retinitis pigmentosa.

Authors:  Parker E Ludwig; S Caleb Freeman; Adam C Janot
Journal:  Int J Retina Vitreous       Date:  2019-02-13

10.  Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study.

Authors:  Jing Cui; Ji-Ping Ren; Dong-Ning Chen; Zhong Xin; Ming-Xia Yuan; Jie Xu; Qi-Sheng You; Jin-Kui Yang
Journal:  BMJ Open       Date:  2017-08-30       Impact factor: 2.692

View more
  14 in total

Review 1.  Mesenchymal stem cell-derived exosomes: a promising vector in treatment for diabetes and its microvascular complications.

Authors:  Xinjie Cui; Liangxi Zhu; Ruixia Zhai; Bin Zhang; Fanyong Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 2.  Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases.

Authors:  Olga Martinez-Arroyo; Ana Ortega; Maria J Forner; Raquel Cortes
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

Review 3.  Roles of Exosomes in Ocular Diseases.

Authors:  Jia Liu; Feng Jiang; Yu Jiang; Yicheng Wang; Zelin Li; Xuefeng Shi; Yanping Zhu; Hongbo Wang; Zhuhong Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-29

Review 4.  Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.

Authors:  Chen Li; Yu-Qing Ni; Hui Xu; Qun-Yan Xiang; Yan Zhao; Jun-Kun Zhan; Jie-Yu He; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2021-11-10

Review 5.  miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.

Authors:  Xingyu Chang; Guomao Zhu; Zongyan Cai; Yaqi Wang; Rongna Lian; Xulei Tang; Chengxu Ma; Songbo Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-10       Impact factor: 5.555

6.  CircZNF532 knockdown protects retinal pigment epithelial cells against high glucose-induced apoptosis and pyroptosis by regulating the miR-20b-5p/STAT3 axis.

Authors:  Gao-Hua Liang; Yan-Ni Luo; Ri-Zhang Wei; Jia-Yang Yin; Zhi-Liang Qin; Li-Li Lu; Wen-Hao Ma
Journal:  J Diabetes Investig       Date:  2022-02-11       Impact factor: 3.681

7.  Exosomes Derived From Human Gingival Mesenchymal Stem Cells Attenuate the Inflammatory Response in Periodontal Ligament Stem Cells.

Authors:  Jiayao Sun; Zhiguo Wang; Peng Liu; Yingzhe Hu; Tingting Li; Jianbo Yang; Pengyu Gao; Quanchen Xu
Journal:  Front Chem       Date:  2022-04-06       Impact factor: 5.545

Review 8.  Association of BMI with Clinicopathological Features of Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.

Authors:  R J O'Neill; S Abd Elwahab; M J Kerin; A J Lowery
Journal:  World J Surg       Date:  2021-06-16       Impact factor: 3.352

Review 9.  Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases.

Authors:  Giuliana Mannino; Cristina Russo; Anna Longo; Carmelina Daniela Anfuso; Gabriella Lupo; Debora Lo Furno; Rosario Giuffrida; Giovanni Giurdanella
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

10.  Lysophosphatidylcholine Offsets the Protective Effects of Bone Marrow Mesenchymal Stem Cells on Inflammatory Response and Oxidative Stress Injury of Retinal Endothelial Cells via TLR4/NF-κB Signaling.

Authors:  Haijun Zhao; Yanhui He
Journal:  J Immunol Res       Date:  2021-10-14       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.